Outcomes of non-hospitalized patients with COVID-19 versus seasonal influenza during the fall-winter 2022–2023 period

Abstract Background The comparability of outcomes for non-hospitalized COVID-19 outpatients during the Omicron wave to outpatients with influenza remains uncertain. This study aims to compare the outcomes of non-hospitalized outpatients with COVID-19 and seasonal influenza during the fall-winter of...

Full description

Saved in:
Bibliographic Details
Main Authors: Wan-Hsuan Hsu, Bo-Wen Shiau, Ya-Wen Tsai, Jheng-Yan Wu, Ting-Hui Liu, Po-Yu Huang, Min-Hsiang Chuang, Chih-Cheng Lai
Format: Article
Language:English
Published: BMC 2025-03-01
Series:BMC Infectious Diseases
Subjects:
Online Access:https://doi.org/10.1186/s12879-025-10833-6
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849733327334932480
author Wan-Hsuan Hsu
Bo-Wen Shiau
Ya-Wen Tsai
Jheng-Yan Wu
Ting-Hui Liu
Po-Yu Huang
Min-Hsiang Chuang
Chih-Cheng Lai
author_facet Wan-Hsuan Hsu
Bo-Wen Shiau
Ya-Wen Tsai
Jheng-Yan Wu
Ting-Hui Liu
Po-Yu Huang
Min-Hsiang Chuang
Chih-Cheng Lai
author_sort Wan-Hsuan Hsu
collection DOAJ
description Abstract Background The comparability of outcomes for non-hospitalized COVID-19 outpatients during the Omicron wave to outpatients with influenza remains uncertain. This study aims to compare the outcomes of non-hospitalized outpatients with COVID-19 and seasonal influenza during the fall-winter of 2022–2023. Methods This is a retrospective cohort study using TriNetX, a collaborative clinical research platform. Non-hospitalized outpatients with COVID-19 and seasonal influenza between 01 October 2022 and 31 January 2023 were selected from TriNetX. Propensity score matching (PSM) was used to compare patients receiving corresponding outpatient antiviral treatments. Hazard ratios (HRs) with 95% confidence intervals (CIs) for the primary outcome—a composite of all-cause emergency department (ED) visits, hospitalizations, or mortality during the 30-day follow-up period—were calculated and compared. Results After PSM, two well-balanced groups of 9,030 patients each were identified. Non-hospitalized COVID-19 patients had a lower risk of primary composites outcomes including all-cause ED visits, hospitalization, or mortality (5.9% vs. 9.2%, HR, 0.661[95% CI, 0.593–0.737]) compared to the influenza group. In addition, the COVID-19 group demonstrated a reduced risk of all-cause ED visits (4.4% vs. 6.6%, HR 0.683[0.601–0.776]), hospitalization (1.7% vs. 2.9%, HR 0.605[0.495–0.739]) and mortality (0.1% vs. 0.2%, HR 0.176[0.052–0.597]), respectively. Conclusions This study indicates a lower risk of all-cause ED visits, hospitalization, and mortality in the non-hospitalized COVID-19 patients compared to the seasonal influenza group, supporting the current public health strategy of adjusting COVID-19 management based on approaches used for seasonal influenza.
format Article
id doaj-art-05c878855c8f463d8e2d6cd758f634cc
institution DOAJ
issn 1471-2334
language English
publishDate 2025-03-01
publisher BMC
record_format Article
series BMC Infectious Diseases
spelling doaj-art-05c878855c8f463d8e2d6cd758f634cc2025-08-20T03:08:05ZengBMCBMC Infectious Diseases1471-23342025-03-012511910.1186/s12879-025-10833-6Outcomes of non-hospitalized patients with COVID-19 versus seasonal influenza during the fall-winter 2022–2023 periodWan-Hsuan Hsu0Bo-Wen Shiau1Ya-Wen Tsai2Jheng-Yan Wu3Ting-Hui Liu4Po-Yu Huang5Min-Hsiang Chuang6Chih-Cheng Lai7Department of Internal Medicine, Chi Mei Medical CenterDepartment of Internal Medicine, Chi Mei Medical CenterCenter of Integrative Medicine, Chi Mei Medical CenterDepartment of Nutrition, Chi Mei Medical CenterDepartment of Psychiatry, Chi Mei Medical CenterDepartment of Internal Medicine, Chi Mei Medical CenterDepartment of Internal Medicine, Chi Mei Medical CenterDepartment of Intensive Care Medicine, Chi Mei Medical CenterAbstract Background The comparability of outcomes for non-hospitalized COVID-19 outpatients during the Omicron wave to outpatients with influenza remains uncertain. This study aims to compare the outcomes of non-hospitalized outpatients with COVID-19 and seasonal influenza during the fall-winter of 2022–2023. Methods This is a retrospective cohort study using TriNetX, a collaborative clinical research platform. Non-hospitalized outpatients with COVID-19 and seasonal influenza between 01 October 2022 and 31 January 2023 were selected from TriNetX. Propensity score matching (PSM) was used to compare patients receiving corresponding outpatient antiviral treatments. Hazard ratios (HRs) with 95% confidence intervals (CIs) for the primary outcome—a composite of all-cause emergency department (ED) visits, hospitalizations, or mortality during the 30-day follow-up period—were calculated and compared. Results After PSM, two well-balanced groups of 9,030 patients each were identified. Non-hospitalized COVID-19 patients had a lower risk of primary composites outcomes including all-cause ED visits, hospitalization, or mortality (5.9% vs. 9.2%, HR, 0.661[95% CI, 0.593–0.737]) compared to the influenza group. In addition, the COVID-19 group demonstrated a reduced risk of all-cause ED visits (4.4% vs. 6.6%, HR 0.683[0.601–0.776]), hospitalization (1.7% vs. 2.9%, HR 0.605[0.495–0.739]) and mortality (0.1% vs. 0.2%, HR 0.176[0.052–0.597]), respectively. Conclusions This study indicates a lower risk of all-cause ED visits, hospitalization, and mortality in the non-hospitalized COVID-19 patients compared to the seasonal influenza group, supporting the current public health strategy of adjusting COVID-19 management based on approaches used for seasonal influenza.https://doi.org/10.1186/s12879-025-10833-6COVID-19InfluenzaAmbulatoryOutpatientMortalityOutcome
spellingShingle Wan-Hsuan Hsu
Bo-Wen Shiau
Ya-Wen Tsai
Jheng-Yan Wu
Ting-Hui Liu
Po-Yu Huang
Min-Hsiang Chuang
Chih-Cheng Lai
Outcomes of non-hospitalized patients with COVID-19 versus seasonal influenza during the fall-winter 2022–2023 period
BMC Infectious Diseases
COVID-19
Influenza
Ambulatory
Outpatient
Mortality
Outcome
title Outcomes of non-hospitalized patients with COVID-19 versus seasonal influenza during the fall-winter 2022–2023 period
title_full Outcomes of non-hospitalized patients with COVID-19 versus seasonal influenza during the fall-winter 2022–2023 period
title_fullStr Outcomes of non-hospitalized patients with COVID-19 versus seasonal influenza during the fall-winter 2022–2023 period
title_full_unstemmed Outcomes of non-hospitalized patients with COVID-19 versus seasonal influenza during the fall-winter 2022–2023 period
title_short Outcomes of non-hospitalized patients with COVID-19 versus seasonal influenza during the fall-winter 2022–2023 period
title_sort outcomes of non hospitalized patients with covid 19 versus seasonal influenza during the fall winter 2022 2023 period
topic COVID-19
Influenza
Ambulatory
Outpatient
Mortality
Outcome
url https://doi.org/10.1186/s12879-025-10833-6
work_keys_str_mv AT wanhsuanhsu outcomesofnonhospitalizedpatientswithcovid19versusseasonalinfluenzaduringthefallwinter20222023period
AT bowenshiau outcomesofnonhospitalizedpatientswithcovid19versusseasonalinfluenzaduringthefallwinter20222023period
AT yawentsai outcomesofnonhospitalizedpatientswithcovid19versusseasonalinfluenzaduringthefallwinter20222023period
AT jhengyanwu outcomesofnonhospitalizedpatientswithcovid19versusseasonalinfluenzaduringthefallwinter20222023period
AT tinghuiliu outcomesofnonhospitalizedpatientswithcovid19versusseasonalinfluenzaduringthefallwinter20222023period
AT poyuhuang outcomesofnonhospitalizedpatientswithcovid19versusseasonalinfluenzaduringthefallwinter20222023period
AT minhsiangchuang outcomesofnonhospitalizedpatientswithcovid19versusseasonalinfluenzaduringthefallwinter20222023period
AT chihchenglai outcomesofnonhospitalizedpatientswithcovid19versusseasonalinfluenzaduringthefallwinter20222023period